Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: shareholder meeting

Perhaps you missed the couple of times it was posted way back then, but the company itself responded to that question directly to those who e-mailed it, and they indicated that they considered the words grant and purchase interchangeably with respect to those who obtained MMP licenses.

Furthermore, to agree to settle a lawsuit in exchange for purchasing a license for the disputed technology would to most reasonable people constititute a "business resolution", especially when constrated to a "litigated solution".

Share
New Message
Please login to post a reply